New treatment guideline for SD in Asian patientsShared by:
Seborrheic dermatitis (SD) is common in Asia, but until now there have not been any standardized clinical diagnostic criteria or any grading system for guiding treatment selection for Asian patients. International guidelines based on Caucasian patients are generally not applicable since there are clinically significant differences in the skin of Asian and Caucasian patients. To address this issue, a consensus group of experts from Asia recently published a new treatment guideline for Asian patients with SD that includes comprehensive treatment algorithms to help physicians select appropriate SD therapies. Dr Wai Kwong Cheong, a specialist in private practice in Singapore, and Dr Ma. Teresita Gabriel from the Research Institute for Tropical Medicine, Muntinlupa City, Philippines, discussed the new guidelines at the 2nd Asia Pacific Meeting of Experts in Dermatology held recently in Hanoi, Vietnam. They highlighted the need to avoid long-term steroid therapy as well as the potential benefits associated with nonsteroidal anti-inflammatory agents with antifungal properties (AIAFp).
15 Nov 2016 - General